Now in its seventh year, the Global Pharma Manufacturing Summit has grown into the premier networking opportunity for industry leaders involved in small molecule and biologic pharma manufacturing. Senior executives and decision-makers from across the pharmaceutical industry will spend two days this June discussing solutions to the universal challenges facing every organization in the current age of transition and austerity.

Pharma manufacturers are facing an ever-growing pressure to grow and evolve beyond the strategies of the past: New technologies, emerging markets, heightened regulatory guidelines, and the oncoming wave of generic products are shaping a new and exciting chapter for the pharmaceutical industry. That’s why this year’s agenda is going to focus on key issues including:

• Manufacturing Excellence
  
• Quality Management
  
• Outsourcing and Contract Manufacturing
  
• Emerging Markets
  
• Supply Chain Management
  
• Continuous Manufacturing
  
• Cost of Goods Reduction
  
• Facility of the Future
  
• Moving Beyond Regulatory Compliance